Paper Details

  1. Home
  2. Paper Details

Role of broxaterol in bronchial hyperresponsiveness.

Author: BiancoS

ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.

Overview

This review of double-blind, randomized controlled studies in asthmatic patients found that broxaterol, a beta 2-agonist, effectively protected against bronchial hyperresponsiveness induced by methacholine, exercise, and allergen. Broxaterol's protective effect was similar to that of terbutaline and salbutamol, but with a lower frequency of side effects. Broxaterol is a promising new alternative to other beta 2-agonists for the management of asthma.
Paper Details　
Original Abstract of the Article :
The protective effect of broxaterol against bronchial hyperresponsiveness has been assessed in several double-blind randomized controlled studies in stable asthmatic patients. In three cross-over studies, broxaterol (400 micrograms by metered dose inhaler) has been shown to significantly reduce meth...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.1159/000195766

データ提供：米国国立医学図書館（NLM）

Broxaterol: A Potential Oasis in the Desert of Asthma

The world of asthma research is a vast and challenging landscape, much like a desert with many hidden dangers. This study examines the potential of broxaterol, a new bronchodilator, as a treatment for bronchial hyperresponsiveness, a key feature of asthma. The authors conducted a series of randomized controlled trials, akin to meticulously mapping out different paths across the desert, to assess the effectiveness of broxaterol compared to other commonly used bronchodilators. Their findings suggest that broxaterol offers a promising new approach to managing asthma, providing relief from bronchospasm and potentially reducing the frequency of exacerbations. It's as if broxaterol acts like a cool, refreshing oasis in the desert, providing respite from the harshness of asthma symptoms.

Broxaterol: A New Weapon in the Arsenal Against Asthma

This study demonstrates that broxaterol, when compared to placebo and other bronchodilators, effectively reduces bronchial hyperresponsiveness, a crucial step in managing asthma. The results are particularly encouraging in light of the potential for broxaterol to be a valuable addition to the current treatment options for asthma, much like a new and reliable source of water in a parched desert.

Navigating the Asthma Desert

This study highlights the importance of finding the right treatment for asthma, just as a camel needs to find the right oasis for its journey. The authors suggest that broxaterol holds promise as a new, effective option for managing asthma, offering a potential oasis in the desert of asthma symptoms.

Dr.Camel's Conclusion

Broxaterol emerges as a potential new weapon in the fight against asthma, offering a promising oasis in the desert of asthma symptoms. The results of this study suggest that broxaterol effectively reduces bronchial hyperresponsiveness, a key factor in managing asthma. This research provides valuable insights into the potential of new bronchodilators for improving the lives of those living with asthma.

Date :
  1. Date Completed 1989-11-09
  2. Date Revised 2018-02-16
Further Info :

Pubmed ID

2572037

DOI: Digital Object Identifier

10.1159/000195766

Related Literature

Article Analysis
・Side Effects of albuterol oral inhalation
SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.